TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
申请人:Genentech, Inc.
公开号:US20160185780A1
公开(公告)日:2016-06-30
Compounds of Formula 0, Formula I and Formula II and methods of use as Janus kinase inhibitors are described herein.
本文描述了化学式为0、化学式I和化学式II的化合物以及作为Janus激酶抑制剂的使用方法。
Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors
申请人:Incyte Corporation
公开号:US20160272648A1
公开(公告)日:2016-09-22
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
Ultrasound in Organic Syntheses. XIX. Further Studies on the Conjugate Additions to Electron Deficient Olefins in Aqueous Media
作者:C. Dupuy、C. Petrier、L. A. Sarandeses、J. L. Luche
DOI:10.1080/00397919108020831
日期:1991.3
Alkyl halides add smoothly to a variety of olefinic bonds conjugated with electron withdrawing groups, in the presence of zinc-copper couple. Sonication enhances the efficiency of the process, which takes place in aqueous media following, most probably, a radical pathway.